BioPharma Pharma Research

Invitae Highlights the Value of Genetic Testing

- Study finds improved seizure control and positive outcomes in 75 percent of patients with actionable genetic findings that led to clinical management cha...

 September 27, 2021 | News

Takeda Breaks Ground on its First Zero Energy Building in Singapore

Takeda Pharmaceutical Company Limited  (TSE:4502/NYSE:TAK) (“Takeda”) announced today the official groundbreaking of its first building&n...

 September 23, 2021 | News

Singapore Approved New Therapy to Treat Advanced Small Cell Lung Cancer

  ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20...

 September 23, 2021 | News

GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes

GeneDx, Inc., a leader in genomic analysis, a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today an...

 September 22, 2021 | News

Vetter Long-term sustainability strategy of pharmaceutical service provider pays off

Continuous investment in energy-efficient and eco-friendly technology Purchasing green energy and offering sustainable mobility solutions Supportin...

 September 21, 2021 | News

Illumina reaffirms commitment to the National Project of Bio Big Data in Korea

The multi-ministerial project is overseen by the Ministry of Health and Welfare, Ministry of Trade and Industry, Ministry of Science and ICT, and Korea Dis...

 September 20, 2021 | News

Terumo celebrates 100-year anniversary in Asia with an eye to the future

Terumo Asia Holdings was established as a subsidiary of Terumo Corporation in 2012. The subsidiary oversees 14 Asia entities across 9 countries. Forg...

 September 20, 2021 | News

FDA granted premarket approval to Thermo Fisher Scientific's Oncomine Dx Target Test

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations The U.S. Food and...

 September 16, 2021 | News

Australia Approved New Therapy to Treat Advanced Small Cell Lung Cancer

Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-line metastatic SCLC in Australia in more tha...

 September 15, 2021 | News

Everest Medicines to Advance mRNA Vaccines in Emerging Markets in Asia

Providence grants Everest license to develop and market potentially "Best-In-Class" mRNA COVID-19vaccine for select Asia territories Provid...

 September 15, 2021 | News

BC Platforms to Enable Longitudinal RWD and Genomics Access for Drug Development in Africa

 BC Platforms (BCP), a global leader in genomics research, analytics and global data access, announced a new collaboration with the African ...

 September 14, 2021 | News

China strengthen it's Proton Therapy System

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research...

 September 13, 2021 | News

Happiness Biotech Announced The Launch of Its Lucidum Tablets

"To prevent false advertisement in the healthcare industry and prohibit defective health products from entering the market, China has set forth s...

 September 13, 2021 | News

Cytiva triples single-use consumables capacity in China

Three new manufacturing lines were successfully launched in under ten months, with an  additional eight new lines planned to launch in Q3 2022.&nbs...

 September 10, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close